These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24695620)

  • 1. The Use of Antibodies in Small-Molecule Drug Discovery.
    Marsden CJ; Eckersley S; Hebditch M; Kvist AJ; Milner R; Mitchell D; Warwicker J; Marley AE
    J Biomol Screen; 2014 Jul; 19(6):829-38. PubMed ID: 24695620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New concepts and aids to facilitate crystallization.
    Bukowska MA; Grütter MG
    Curr Opin Struct Biol; 2013 Jun; 23(3):409-16. PubMed ID: 23578532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of chemical biology in target identification and drug discovery.
    Zhu Y; Xiao T; Lei S; Zhou F; Wang MW
    Arch Pharm Res; 2015 Sep; 38(9):1642-50. PubMed ID: 26242900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput proteomics using antibody microarrays.
    Wingren C; Borrebaeck CA
    Expert Rev Proteomics; 2004 Oct; 1(3):355-64. PubMed ID: 15966831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoproteomic approaches to drug target identification and drug profiling.
    Bantscheff M; Drewes G
    Bioorg Med Chem; 2012 Mar; 20(6):1973-8. PubMed ID: 22130419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target identification of small molecules based on chemical biology approaches.
    Futamura Y; Muroi M; Osada H
    Mol Biosyst; 2013 May; 9(5):897-914. PubMed ID: 23354001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant antibodies for the generation of antibody arrays.
    Borrebaeck CA; Wingren C
    Methods Mol Biol; 2011; 785():247-62. PubMed ID: 21901605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target identification for biologically active small molecules using chemical biology approaches.
    Lee H; Lee JW
    Arch Pharm Res; 2016 Sep; 39(9):1193-201. PubMed ID: 27387321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrayed protein library technology for therapeutic biologic discovery.
    Mao H; Graziano J; Smider VV
    Biotechnol Genet Eng Rev; 2012; 28():131-45. PubMed ID: 22616485
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of biosensor technology for the engineering of antibodies and enzymes.
    Huber A; Demartis S; Neri D
    J Mol Recognit; 1999; 12(3):198-216. PubMed ID: 10398410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering of recombinant crystallization chaperones.
    Koide S
    Curr Opin Struct Biol; 2009 Aug; 19(4):449-57. PubMed ID: 19477632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Phenotypic Hit to Chemical Probe: Chemical Biology Approaches to Elucidate Small Molecule Action in Complex Biological Systems.
    Pasquer QTL; Tsakoumagkos IA; Hoogendoorn S
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery.
    Jung HJ; Kwon HJ
    Arch Pharm Res; 2015 Sep; 38(9):1627-41. PubMed ID: 26040984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics and systems biology: application in drug discovery and development.
    Chakravarti B; Mallik B; Chakravarti DN
    Methods Mol Biol; 2010; 662():3-28. PubMed ID: 20824464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches.
    Kubota K; Funabashi M; Ogura Y
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):22-27. PubMed ID: 30392561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic protease inhibitors as novel therapeutic agents.
    Scott CJ; Taggart CC
    Biochimie; 2010 Nov; 92(11):1681-8. PubMed ID: 20346385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.
    Agarwal P; Bertozzi CR
    Bioconjug Chem; 2015 Feb; 26(2):176-92. PubMed ID: 25494884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical proteomics and its application to drug discovery.
    Jeffery DA; Bogyo M
    Drug Discov Today; 2004 Jan; 9(2 Suppl):S19-26. PubMed ID: 23573640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen generation and display in therapeutic antibody drug discovery -- a neglected but critical player.
    Ebersbach H; Geisse S
    Biotechnol J; 2012 Dec; 7(12):1433-43. PubMed ID: 23139179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity proteomics: the role of specific binding reagents in human proteome analysis.
    Stoevesandt O; Taussig MJ
    Expert Rev Proteomics; 2012 Aug; 9(4):401-14. PubMed ID: 22967077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.